MarketsSingle-source
2.0
Corvus Pharmaceuticals reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·about 2 hours ago
GBT Technologies Inc. filed an 8-K disclosing a change in corporate governance under Item 5.02. The filing confirms the departure of a director or officer, though specific names and reasons remain subject to the full document disclosure.